Lortab and Timentin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lortab (acetaminophen; hydrocodone bitartrate) and Timentin (clavulanate potassium; ticarcillin disodium). Common drug interactions include herpes zoster among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Lortab and Timentin. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Lortab?

Lortab has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 31,285 Lortab users. Check the latest studies of Lortab.

What is Timentin?

Timentin has active ingredients of clavulanate potassium; ticarcillin disodium. eHealthMe is studying from 624 Timentin users. Check the latest studies of Timentin.



On Jul, 11, 2026

25 people who take Lortab and Timentin together, and have interactions are studied.

Lortab and Timentin drug interactions.

What are the common drug interactions of Lortab and Timentin, by gender? *:

female:

  1. Herpes zoster
  2. Inflammation
  3. Influenza
  4. Injury
  5. Migraine (headache)
  6. Multiple myeloma (cancer of the plasma cells)
  7. Neutropenia (an abnormally low number of neutrophils)
  8. Osteopenia (a condition where bone mineral density is lower than normal)
  9. Pleural effusion (water on the lungs)
  10. Rectal haemorrhage (bleeding from anus)

male:

  1. Cardiac failure congestive
  2. Dementia (madness)
  3. Escherichia test positive
  4. General physical health deterioration (weak health status)
  5. Hypotension (abnormally low blood pressure)
  6. Loss of consciousness
  7. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  8. Nausea (feeling of having an urge to vomit)
  9. Renal failure acute (rapid kidney dysfunction)
  10. Renal failure chronic (long lasting kidney dysfunction)

What are the common drug interactions of Lortab and Timentin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abscess jaw (tooth abscess or root abscess)
  2. Anaemia of chronic disease
  3. Anxiety
  4. Arteriosclerosis (thickening and hardening of arteries)
  5. Arthralgia (joint pain)
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  7. Arthropathy
  8. Asthenia (weakness)
  9. Atelectasis (partial or complete collapse of the lung)
  10. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)

30-39:

  1. Asthma
  2. Autoimmune hepatitis
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Weakness
  5. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  6. Constipation
  7. Cytomegalovirus infection
  8. Fatigue (feeling of tiredness)
  9. Hepatitis (inflammation of the liver)
  10. Hepatomegaly (abnormal enlargement of the liver)

40-49:

n/a

50-59:

  1. Blood potassium decreased
  2. Cardiac failure congestive
  3. Cerebral atrophy (decrement in size of brain)
  4. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  7. Cold sweat
  8. Confusional state
  9. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  10. Diabetes mellitus inadequate control

60+:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Anxiety
  3. Osteopenia (a condition where bone mineral density is lower than normal)
  4. Pleural effusion (water on the lungs)
  5. Rectal haemorrhage (bleeding from anus)
  6. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Cardiomegaly (increased size of heart than normal)
  9. Chills (felling of cold)
  10. Constipation

* Approximation only. Some reports may have incomplete information.

Do you take Lortab and Timentin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lortab and Timentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lortab:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Timentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lortab and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Timentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; hydrocodone bitartrate and clavulanate potassium; ticarcillin disodium (the active ingredients of Lortab and Timentin, respectively), and Lortab and Timentin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: